Distinguished in Thrombocytopenia

Martin R. Schipperus

Amsterdam, NH, NL 
Distinguished in Thrombocytopenia
Amsterdam, NH, NL 
OverviewLocationsClinical Research

Overview

Martin Schipperus practices in Amsterdam, Netherlands. Mr. Schipperus is rated as a Distinguished expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Purpura, Splenectomy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 65 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 20 articles and participated in 2 clinical trials in the study of Thrombocytopenia.

Gender
Male

Locations

Amsterdam, NH, Netherlands
Other Locations
Rotterdam, ZH, Netherlands
The Hague, Netherlands
Groningen, GR, Netherlands
Leiden, ZH, Netherlands
Leyenburg, ZH, Netherlands
HagaZiekenhuis
Haag, LI, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Enrollment Status: Completed
Publish Date: September 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

65 Total Publications

Toward Personalized Transfusion Strategies: The Emerging Role of Wearable Biosensors in Chronic Anemia Management.
Toward Personalized Transfusion Strategies: The Emerging Role of Wearable Biosensors in Chronic Anemia Management.
Journal: Transfusion medicine reviews
Published: May 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schipperus's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile